Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 2/20 | 0.36 |
| ▸ | SI | P14410 | 2/20 | 0.32 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | GBA1 | P04062 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28530966 | 0.83 | MGAM (0.31) | SIMGAMGAA | |
| SCHEMBL12166570 | 0.82 | MGAM (0.31) | APLNRSIMGAMGAA | |
| SCHEMBL12350858 | 0.80 | EPHX2 (0.33) | SIMGAMGAAEPHX2 | |
| SCHEMBL17049037 | 0.80 | — | — | |
| SCHEMBL4660385 | 0.77 | EPHX2 (0.43) | APLNREPHX2 | |
| SCHEMBL3627748 | 0.77 | APLNR (0.39) | APLNRSIMGAMGAA | |
| SCHEMBL27647013 | 0.71 | APLNR (0.31) | APLNR | |
| SCHEMBL2404479 | 0.71 | — | — | |
| SCHEMBL13741606 | 0.70 | APLNR (0.48) | APLNRGBA1EPHX2 | |
| SCHEMBL1358694 | 0.69 | APLNR (0.39) | APLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6215031-B1 | REDUCING 3-FORMYLCYCLOALKANONE OR 3-FORMYLCYCLOALKENONE;3-HYDROXYMETHYL-5,5-DIMETHYLCYCLOHEXANOL | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2001-04-10 | — | — | US | claimed |
| EP-0895980-A1 | 3-HYDROXYMETHYLCYCLOALKANOLS AND PROCESS FOR PRODUCING THEM | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-02-10 | — | — | EP | claimed |
| JP-10204012-A | — | — | None | — | — | JP | disclosed |
| CN-1308338-C | Phosphorus compound | DAICEL CHEM (JP) | 2007-04-04 | — | — | CN | disclosed |
| CN-1224625-C | Phosphorus-containing compound | DAICEL CHEM (JP) | 2005-10-26 | — | — | CN | disclosed |
| CN-1597686-A | Phosphorus compound | DAICEL CHEM (JP) | 2005-03-23 | — | — | CN | disclosed |
| US-6794528-B2 | HEAT RESISTANCE, FLAME RETARDERS, STABILIZERS; REACTING DIALCOHOL COMPOUND WITH A PHOSPHYL OXYCHLORIDE COMPOUND | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-09-21 | — | — | US | disclosed |
| US-20030109736-A1 | Phosphorus compound | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-06-12 | — | — | US | disclosed |
| EP-1277758-A1 | PHOSPHORUS COMPOUND | Daicel Chemical Industries, Ltd. (JP) | 2003-01-22 | — | — | EP | disclosed |
| CN-1383429-A | Phosphorus-containing compound | DAICEL CHEM (JP) | 2002-12-04 | — | — | CN | disclosed |
| US-6215031-B1 | REDUCING 3-FORMYLCYCLOALKANONE OR 3-FORMYLCYCLOALKENONE;3-HYDROXYMETHYL-5,5-DIMETHYLCYCLOHEXANOL | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2001-04-10 | — | — | US | disclosed |
| EP-0895980-A1 | 3-HYDROXYMETHYLCYCLOALKANOLS AND PROCESS FOR PRODUCING THEM | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-02-10 | — | — | EP | disclosed |
| JP-H10204012-A | 3-HYDROXYMETHYL CYCLOALKANOL AND ITS PRODUCTION | DAICEL CHEM IND LTD | 1998-08-04 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030109736-A1 | Phosphorus compound | NR4A1, POLL, NR0B1 | APLNR 3248/4885SI 4687/4885MGAM 3893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.